These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1450477

  • 1. Disordered breathing patterns during bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone membranes.
    Navarro J, Serrano C, Donna E, Perez GO.
    ASAIO J; 1992; 38(4):811-4. PubMed ID: 1450477
    [Abstract] [Full Text] [Related]

  • 2. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
    Eiselt J, Racek J, Holecek V, Krejcová I, Opatrný K.
    Cas Lek Cesk; 1996 Nov 06; 135(21):691-4. PubMed ID: 8998818
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
    Panichi V, Rizza GM, Taccola D, Paoletti S, Mantuano E, Migliori M, Frangioni S, Filippi C, Carpi A.
    Biomed Pharmacother; 2006 Jan 06; 60(1):14-7. PubMed ID: 16330177
    [Abstract] [Full Text] [Related]

  • 4. [Immediate effect of hemodialysis with cuprophane membrane and acetate containing dialysis fluid on respiratory function in patients with chronic renal failure].
    Wanic-Kossowska M.
    Pol Tyg Lek; 2006 Jan 06; 48(7-8):175-7. PubMed ID: 8415262
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition.
    Kiykim AA, Horoz M, Ozcan T, Yildiz I, Sari S, Genctoy G.
    Ren Fail; 2010 Jan 06; 32(10):1148-52. PubMed ID: 20954973
    [Abstract] [Full Text] [Related]

  • 6. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.
    Ljungberg B, Jacobson SH, Lins LE, Pejler G.
    Clin Nephrol; 1992 Aug 06; 38(2):97-100. PubMed ID: 1325310
    [Abstract] [Full Text] [Related]

  • 7. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM, Youssef AM, Zayoon MY.
    Hemodial Int; 2006 Oct 06; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [Abstract] [Full Text] [Related]

  • 8. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI, Braga Lopes C, Magalhães CA, Schleicher CC, Veiga JP.
    Life Sci; 2005 Nov 04; 77(25):3141-55. PubMed ID: 16005905
    [Abstract] [Full Text] [Related]

  • 9. Protein catabolism in sham-hemodialysis: the effect of different membranes.
    Gutierrez A, Bergström J, Alvestrand A.
    Clin Nephrol; 1992 Jul 04; 38(1):20-9. PubMed ID: 1499165
    [Abstract] [Full Text] [Related]

  • 10. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S, Kehinde Z, Arije A, Salako BL.
    Afr J Med Med Sci; 2001 Sep 04; 30(3):191-4. PubMed ID: 14510127
    [Abstract] [Full Text] [Related]

  • 11. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun 04; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 12. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C, Heintz B, Sieberth HG.
    Clin Nephrol; 1999 Nov 04; 52(5):312-21. PubMed ID: 10584995
    [Abstract] [Full Text] [Related]

  • 13. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J, Bartelik S, Sarnecka S.
    Wiad Lek; 1994 Jul 04; 47(13-14):523-6. PubMed ID: 7716940
    [Abstract] [Full Text] [Related]

  • 14. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A, Coen G, Manni M, Perruzza I, Fassino V, Sardella D, Grandi F.
    Artif Organs; 2004 Dec 04; 28(12):1067-75. PubMed ID: 15554934
    [Abstract] [Full Text] [Related]

  • 15. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
    de Gómez Dumm NT, Giammona AM, Touceda LA, Raimondi C.
    Medicina (B Aires); 2001 Dec 04; 61(2):142-6. PubMed ID: 11374135
    [Abstract] [Full Text] [Related]

  • 16. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
    Shahbazian H, Zand Moghadam A, Ehsanpour A, Khazaali M.
    Iran J Kidney Dis; 2009 Jul 04; 3(3):151-5. PubMed ID: 19617664
    [Abstract] [Full Text] [Related]

  • 17. [Thermal energy balance during hemodialysis: the role of the filter membrane].
    Panzetta G, Bianco F, Galli G, Ianche M, Savoldi S, Vianello S, Vidi E, Cicinato P.
    G Ital Nefrol; 2002 Jul 04; 19(4):425-31. PubMed ID: 12369045
    [Abstract] [Full Text] [Related]

  • 18. Bicarbonate versus acetate hemodialysis in ventilated patients.
    van Geelen JA, Woittiez AJ, Schalekamp MA.
    Clin Nephrol; 1987 Sep 04; 28(3):130-3. PubMed ID: 3117466
    [Abstract] [Full Text] [Related]

  • 19. Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes.
    Ifediora OC, Teehan BP, Sigler MH.
    ASAIO J; 1992 Sep 04; 38(3):M697-701. PubMed ID: 1457952
    [Abstract] [Full Text] [Related]

  • 20. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T, Krajewska M.
    Polim Med; 1997 Sep 04; 27(1-2):47-59. PubMed ID: 9380601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.